Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: Evidence for an autocrine, but not a paracrine, mechanism

International Journal of Cancer

Volumn 66, Issue 5, 1996, Pages 669-677

  Potapova, Olga ^a   Fakhrai, Habib ^b   Mercola, Dan ^a,c  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CARCINOGENESIS; CELL TRANSFORMATION; CLONE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0029938496     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19960529)66:5<669::aid-ijc15>3.0.co;2-%23     Document Type: Article

References (40)

1. ARIAD, S., SEYMOUR, L. and BEZWODA, W.R., Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: correlation with stage and rate of progression. Breast Cancer Res. Treat., 20, 11-17 (1991).
2. BETSHOLTZ, C., WESTERMARK, B., EK, B. and HELDIN, C.-H., Coexpression of a PDGF-like growth factor and PDGF receptors in a human osteosarcoma cell line: implication for autocrine receptor activation. Cell, 39, 447-457 (1984).
3. BIGNER, S.H., SCHULD, S.C., FRIEDMAN, H.S., MARK, J. and BIGNER, D.D., Chromosomal composition of malignant human gliomas through serial subcutaneous transplantation in athymic mice. Cancer Genet. Cytogenet., 40, 111-120 (1989).
4. CAMBY, I., ETIEVANT, C., PETEIN, M., DEDECKER, R., VAN VELTHOVEN, R., DANGUY, A., PASTEELS, J.L. and KISS, R., Influence of culture media on the morphological differentiation of the PC-3 and DU145 prostatic neoplastic cell lines. Prostate, 24, 187-196 (1994).
5. DEVARE, S.G., REDDY, E.P., LAW, J.D., ROBBINS, K.C. and AARONSON, S.A., Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc. nat. Acad. Sci. (Wash.), 80, 731-735 (1983).
6. DOOLITTLE, R.G., HUNKAPILLER, M.W., HOOD, L.E., DEVARE, S.G., ROBBINS, K.C., AARONSON, S.A. and ANTONIADES, H.N., Simian sarcoma virus one gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science, 221, 275-277 (1983).
7. DRUMMOND-BARBOSA, D., VAILLANCOURT, R.R., KAZLAUSKAS, A. and MIMAIO, D., Ligand-independent activation of the platelet-derived growth factor β receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol. cell. Biol., 15, 2570-2581 (1995).
8. FIDLER, I.J. and ELLIS, L.M., The implications of angiogenesis for the biology and therapy of cancer metastases. Cell, 79, 185-189 (1994).
9. FORSBERG, K., VALYI-NAGI, I., HELDIN, C.-H., HERLYN, M. and WESTERMARK, B., Platelet-derived growth factor (PDGF) in oncogenesis: development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB. Proc. nat. Acad. Sci. (Wash.), 90, 393-397 (1993).
10. GOLUB, T.R., BARKER, G.F., LOVETT, M. and GILLAND, D.G., Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5:12) chromosomal translocation. Cell, 77, 307-316 (1994).
11. HAMMACHER, A., MELLSTRÖM. K., HELDIN, C.-H. and WESTERMARK, B., Isoform-specific induction of actin reorganization by plateletderived growth factor suggests that the functionally active receptor is a dimer. EMBO J., 8, 2489-2495 (1989).
12. HARSH, G.R., KEATING, M.T., ESCOBEDO, J.A. and WILLIAMS, L. T. Platelet-derived growth factor (PDGF) autocrine components in human tumor cell lines. J. Neuro-Oncol, 8, 1-12 (1990).
13. HELDIN, C.H., WESTERMARK, B. and WASTERSON, Å., Chemical and biological properties of a growth factor from human-cultured osteosarcoma cells: resemblance with platelet-derived growth factor. J. cell. Physiol., 105, 235-246 (1980).
14. KIMURA, A., NAKATA, Y., HYODO, H., KURAMOTO, A. and SATOW, Y., Platelet-derived growth factor expression in accelerated and blastsc phase of chronic myelogenous leukaemia with myelofibrosis. Brit. J. Haematol., 86, 303-307 (1994).
15. MAURO, A., BULFONE, A., TURCO, E. and SCHIFFER, D., Coexpression of platelet-derived growth factor (PDGF) B chain and PDGF B-type receptor in human gliomas. Childs Nerv. System, 7, 432-436 (1991).
16. MERCER, W.E., SHIELDS, M.T., AMIN, M., SAUVE, G.J., APPELLA, E. ROMANO, J.W. and ULLRICH, S.J., Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc. nat. Acad. Sci. (Wash.), 87, 6166-6170 (1990).
17. MERCOLA, D., Platelet-derived growth factor, transformation and antisense: models wanted. In: R.P. Erickson and J. Izant (eds.). Gene regulation by antisense RNA and DNA, pp. 329-353, Raven Press, New York (1992).
18. MERCOLA, D., CARPENTER, P., GROVER-BARDWICK, A. and MERCOLA, M., Rapid, complete and reversible transformation by v-sis precedes irreversible transformation. Oncogene, 7, 1793-1803 (1992).
19. MERCOLA, M., DEIMNGER, P.L., SHAMAH, S.M., PORTER, J., WANG, C.Y. and STILES, C.D., Dominant-negative mutants of a plateletderived growth factor gene. Genes Develop., 4, 2333-2341 (1990).
20. PONTEN, F., REN, Z., NISTER, M., WESTERMARK, B. and PONTEN, J., Epithelial-stromal interactions in basal cell cancer: the PDGF system. J. invest. Dermatol., 102, 304-409 (1994).
21. POTAPOVA, O., FAKHRAI, H., BAIRD, S. and MERCOLA, D., PDGF-B v-sis confers a tumorigenic and metastatic phenotype to human T9SG glioblastoma cells. Cancer Res., 56, 280-286 (1996).
22. ROMANO, M., VIERO, P., CORTELLAZZO, S., BARBUI, T., DONATI, M.B. and POGGI, A., Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders. Haemostasis, 20, 162-168 (1990).
23. SARIBAN, E., SITRARAS, N., ANTONIADES, H.N., KUFE, D.W. and PANTAZIS, P., Expression of platelet-derived growth factor (PDGF)-related transcripts and synthesis of biologically active PDGF-hke proteins by human malignant epithelial cell lines. J. clin. Invest., 82, 1157-1164 (1988).
24. SEIFERT, R.A., HART, C.E., PHILLIPS, P.E., FORSTROM, J.W., ROSS, R., MURRAY, M.J. and BOWEN-POPE, D.F., Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. J biol. Chem., 264, 8771-8778 (1989).
25. SEYMOUR, L. and BEZWODA, W.R., Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer. Breast Cancer Res. Treat., 32, 229-233 (1994).
26. SHAMAH, S.M., STILES, C.D. and GUHA, A., Dominant-negative mutants of platelet-derived growth factor revert the transformed phenotype of human astrocytoma cells. Mol. cell. Biol., 13, 7203-7212 (1993).
27. SHIH, I.M. and HERLYN, M., Autocrine and paracrine roles for growth factors in melanoma. In Vivo, 8, 113-123 (1994).
28. SITARAS, N.M., SARIBAN, E., BRAVO, M., PANTAZIS, P. and ANTONIADES, H.N., Constitutive production of platelet-derived growth factor-like proteins by human prostate carcinoma cell lines. Cancer Res., 48, 1930-1935 (1988).
29. SMEAL, T., BINÉTRUY, B., MERCOLA, D., BARDWICK-GROVER, A., HEIDECKER, G., RAPP, U. and KARIN, M., Oncoprotein mediated signalling cascade stimulates cJun activity by phosphorylation of serines 63 and 73. Mol. cell. Biol., 12, 3507-3513 (1992).
30. SMEAL, T., BINÉTRUY, B., MERCOLA, D.A., BIRRER, M. and KARIN, M., Phosphorylation of cJun serines 63 and 73 is required for oncogenic and transcriptional cooperation with Ha-Ras. Nature (Lond.), 354, 494-496 (1991).
31. 1 arrest in vivo. J. cell. Physiol., 12, 43-54 (1979).
32. TAKANAMI, I., IMAMURA, T., YAMAMOTO, Y. and KODAIRA, S., Usefulness of platelet-derived growth factor as a prognostic factor in pulmonary adenocarcinoma. J. surg. Oncol, 58, 40-43 (1995).
33. TSAI, L.H., WHITE, L., RAINES, E., Ross, R., SMITH, R.G., CUSHLEY, W. and OZANNE, B., Expression of platelet-derived growth factor and its receptors bv two pre-B acute Iymphocytic leukemia cell lines. Blood. 83, 51-55 (1994).
34. VAN MEIR, E.G., KIKUCHI, T., TADA, M., LI, H., DISERENS, A.C., WOJCIK, B.E., HUANG, H.J., FRIEDMANN, T., DE TRIBOLET, N. and CAVENEE, W.K., Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res. 54, 649-652 (1994).
35. VASSBOTN, F.S., OSTMAN, A., LANGELAND, N., HOLMSEN, H., WESTERMARK, B., HELDLN, C.H. and NISTER, M., Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line. J. cell. Physiol., 158, 381-389 (1994).
36. WANG, J., COLTRERA, M.D. and GOWN, A.M., Cell proliferation in human soft tissue tumors correlates with platelet-derived growth factor B chain expression: an immunohistochemical and in situ hybridization study. Cancer Res., 54, 560-564 (1994).
37. WATERFIELD, M.D., SCRACE, G.T., WHITTLE, N., STROOBANT, P., JOHNSSON, A., WASTERSON, Å., WESTERMARK, B.G., HELDIX, D.-H., HUANG, J.S. and DEUEL, T.G., Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (Lond.), 304, 35-39 (1983).
38. WEINER, T.M., LIU, E.T., CRAVEN, R.J. and CANCE, W.G., Expression of growth factor receptors, the focal adhesion kinase. and other tyrosine kinases in human soft tissue tumors. Ann. surg. Oncol., 1, 18-27 (1994).
39. WESTERMARK, B. and HELDIN, C.H., Platelet-derived growth factor. Structure. function and implications in normal and malignant cell growh. Acta Oncol. 32, 101-105 (1993).
40. Xu, Y.F., MEYER, A.N., WEBSTER, M.K., LEE, B.A. and DONOGHUE, D.J., The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus ES oncoprotein. J. Cell Biol., 123, 549-560 (1993).